Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (14)

« Back to Publications

Statin safety in prevention of cardiovascular diseases: causal inference and risk prediction

Cai T., (2025)

How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses

Abel L. et al, (2024), Health and Quality of Life Outcomes, 22

Physical activity for treatment of irritable bowel syndrome

Nunan D. et al, (2022), Cochrane Database of Systematic Reviews, 2022

PREDICTING INDIVIDUAL RISK OF MUSCLE DISORDERS IN PATIENTS ELIGIBLE FOR STATIN TREATMENT: STRATIFY-STATINMD MODEL DERIVATION USING DATA FROM ELECTRONIC HEALTH RECORDS

Cai T. et al, (2022), Journal of hypertension, 40, e76 - e77

Predicting individual risk of muscle disorders in patients eligible for statin treatment: Derivation and external validation of stratify-statinmd prediction model

Cai T. et al, (2022), PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 31, 285 - 285

Predicting individual risk of muscle disorders in patients eligible for statin treatment: derivation and validation of STRATIFY-StatinMD prediction model

Cai T. et al, (2022), JOURNAL OF HUMAN HYPERTENSION, 36, 10 - 10

PREDICTING INDIVIDUAL RISK OF MUSCLE DISORDERS IN PATIENTS ELIGIBLE FOR STATIN TREATMENT: STRATIFY-STATINMD MODEL DERIVATION USING DATA FROM ELECTRONIC HEALTH RECORDS

Cai T. et al, (2022), JOURNAL OF HYPERTENSION, 40, E76 - E77

PREDICTING INDIVIDUAL RISK OF MUSCLE DISORDERS IN PATIENTS ELIGIBLE FOR STATIN TREATMENT: STRATIFY-STATINMD MODEL DERIVATION USING DATA FROM ELECTRONIC HEALTH RECORDS

Cai T. et al, (2022), JOURNAL OF HYPERTENSION, 40, E76 - E77

ssociations between statins and adverse events in primary prevention of cardiovascular disease: Systematic review with pairwise, network, and dose-response meta-analyses

Cai T. et al, (2021), The BMJ, 374

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review

Dorward J. et al, (2021), Antiviral Therapy, 25, 365 - 376

ssociations between statins and adverse events in primary prevention of cardiovascular disease: a systematic review with meta-analysis

Cai T. et al, (2021), JOURNAL OF HUMAN HYPERTENSION, 35, 11 - 12

Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles.

Yi Z-M. et al, (2019), Neuropsychiatr Dis Treat, 15, 1 - 19

The cardiovascular effect of incretin-based therapies among type 2 diabetes: a systematic review and network meta-analysis

Wu S. et al, (2018), Expert Opinion on Drug Safety, 17, 243 - 249

The effects of dipeptidyl peptidase-4 inhibitors on bone fracture among patients with type 2 diabetes mellitus: A network meta-analysis of randomized controlled trials.

Yang J. et al, (2017), PLoS One, 12